[Effect of asbestos fibre dust exposures on lung function--a systematic review].
Asbestos-induced lung diseases are in addition to skin diseases and hearing impairment due to noise the most frequent occupational diseases. In this connection, many questions arise. They particularly refer to the fine diagnostics and the compensation in case of early stages. This systematic review questions the prevailing practice of getting medical expert opinions. It was shown that already pleural plaques and low stages of lung fibrosis due to asbestos are significantly associated with symptoms of chronic obstructive bronchitis, lymphocytic alveolitis and significant functional restrictions, i. e. FVC, FEV (1) and TLC restrictions, gas exchange impairments (P ((A-a),O2), P (a,O2)), diffusion disorders (D (L,CO)) and an obstructive ventilation pattern (FEV (1)/FVC, FEF values, D (L,CO)). The asbestos fibre dose shows some relation to reductions of FVC, FEV (1), FEF values, and D (L,CO). Only about half of the asbestos-induced functional impairments are related to radiological (inclusive CT) findings. To a lesser degree, these findings also apply to exposed people without pathological chest X-ray findings. The diffusion capacity reduction, at first still within the reference range, is an early indication of a lung lesion caused by asbestos fibres. The same applies to spiroergometric parameters (P ((A-a),O2), V (E/)V (O2), V (D)/V (T)). Reduced lung compliance can also be determinable at an early asbestosis stage. The results of literature research confirmed by statements of international groups of experts indicate continuous pathophysiological processes due to asbestos fibres deposited in peripheral airways and in the lung. These processes are neither radiologically nor histopathologically detectable and occur with a chronic lymphocytic alveolitis. Therefore, diagnostics of asbestos-induced non-malignant lung and pleural changes require comprehensive lung function tests. The outcome may help to estimate the probable remaining life span.
Baur
X
X
Zentralinstitut für Arbeitsmedizin und Maritime Medizin, Universitätsklinikum Hamburg-Eppendorf (Direktor: Prof. Dr. med. X. Baur). Xaver.Baur@bsg.hamburg.de
Wilken
D
D
D001195:Asbestosis / Q000000981:diagnostic imaging* / Q000453:epidemiology; D003430:Cross-Sectional Studies; D004391:Dust; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging; D008176:Lung Volume Measurements; D029424:Pulmonary Disease, Chronic Obstructive / Q000000981:diagnostic imaging* / Q000453:epidemiology; D012016:Reference Values; D012129:Respiratory Function Tests; D012907:Smoking / Q000009:adverse effects / Q000453:epidemiology; D036542:Tomography, Spiral Computed
D004391:Dust